Health CanadaGeneral Alert
The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and ...
Published: December 17, 2008Recall ID: 24296Category: generalCountry: Canada
Product Description & Identification
The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24296 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/use-tarceva-erlotinib-patients-moderate-hepatic-impairment-and-advanced-solid-tumours |
| Title | The use of Tarceva (erlotinib) in patients with moderate hepatic impairment and advanced solid tumours - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2008-12-17 |
| Organization | Marketed health products |